$LVWR
LiveWire Group, Inc. Stock $lvwr

$lvwr Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000189879524000263 Filed on August 07, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$4.445M	$6.449M
YoY Change	-45.42%	-8.21%
Cost Of Revenue	$5.965M	$8.231M
YoY Change	-15.41%	-17.41%
Gross Profit	-$1.520M	-$1.782M
YoY Change	-239.19%	-39.39%
Gross Profit Margin	-34.2%	-27.63%
Selling, General & Admin	$25.01M	$26.38M
YoY Change	-5.41%	-9.16%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.695M	$2.716M
YoY Change	87.15%	288.0%
% of Gross Profit
Operating Expenses	$25.01M	$26.38M
YoY Change	-5.41%	-9.16%
Operating Profit	-$26.53M	-$28.17M
YoY Change	4.66%	-11.94%
Interest Expense	$1.252M	$1.596M
YoY Change	-54.14%	-41.96%
% of Operating Profit
Other Income/Expense, Net	$2.581M	$1.792M
YoY Change
Pretax Income	-$22.69M	-$24.78M
YoY Change	55.65%	-39.07%
Income Tax	$2.000K	$28.00K
% Of Pretax Income
Net Earnings	-$22.69M	-$24.81M
YoY Change	55.67%	-39.1%
Net Earnings / Revenue	-510.55%	-384.63%
Basic Earnings Per Share	-$0.11	-$0.12
Diluted Earnings Per Share	-$0.11	-$0.12
COMMON SHARES
Basic Shares Outstanding	203.3M shares	203.2M shares
Diluted Shares Outstanding	203.3M shares	203.2M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$88.44M	$113.0M
YoY Change	-55.76%	-47.66%
Cash & Equivalents	$88.44M	$113.0M
Short-Term Investments
Other Short-Term Assets	$3.363M	$2.035M
YoY Change	72.82%	-25.18%
Inventory	$33.36M	$34.06M
Prepaid Expenses
Receivables	$2.211M	$2.379M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$127.4M	$151.5M
YoY Change	-46.91%	-40.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$35.83M	$36.82M
YoY Change	-4.95%	3.2%
Goodwill	$8.327M	$8.327M
YoY Change	0.0%	0.0%
Intangibles	$1.122M	$1.185M
YoY Change	-23.31%	-24.9%
Long-Term Investments
YoY Change
Other Assets	$5.647M	$5.896M
YoY Change	-10.63%	-9.15%
Total Long-Term Assets	$50.92M	$53.43M
YoY Change	-9.09%	-2.16%
TOTAL ASSETS
Total Short-Term Assets	$127.4M	$151.5M
Total Long-Term Assets	$50.92M	$53.43M
Total Assets	$178.3M	$204.9M
YoY Change	-39.75%	-34.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.37M	$19.79M
YoY Change	-35.82%	-11.65%
Accrued Expenses	$19.58M	$18.29M
YoY Change	5.86%	7.3%
Deferred Revenue	$205.0K	$183.0K
YoY Change	-52.1%	-11.17%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$35.94M	$38.77M
YoY Change	-20.83%	-5.04%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.587M	$685.0K
YoY Change	1055.42%	61.18%
Total Long-Term Liabilities	$4.587M	$685.0K
YoY Change	1055.42%	61.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.94M	$38.77M
Total Long-Term Liabilities	$4.587M	$685.0K
Total Liabilities	$40.64M	$45.89M
YoY Change	-29.21%	-25.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$203.1M	-$180.4M
YoY Change	105.4%	114.0%
Common Stock	$20.00K	$20.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$137.7M	$159.0M
YoY Change
Total Liabilities & Shareholders Equity	$178.3M	$204.9M
YoY Change	-39.75%	-34.0%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$22.69M	-$24.81M
YoY Change	55.67%	-39.1%
Depreciation, Depletion And Amortization	$2.695M	$2.716M
YoY Change	87.15%	288.0%
Cash From Operating Activities	-$23.10M	-$25.96M
YoY Change	57.38%	55.91%
INVESTING ACTIVITIES
Capital Expenditures	$1.581M	$1.841M
YoY Change	-43.33%	-47.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.581M	-$1.841M
YoY Change	-43.33%	-47.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-222.0K
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-23.10M	-25.96M
Cash From Investing Activities	-1.581M	-1.841M
Cash From Financing Activities	0.000	-222.0K
Net Change In Cash	-24.68M	-28.02M
YoY Change	55.06%	38.86%
FREE CASH FLOW
Cash From Operating Activities	-$23.10M	-$25.96M
Capital Expenditures	$1.581M	$1.841M
Free Cash Flow	-$24.68M	-$27.80M
YoY Change	41.3%	37.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	281000	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	105000	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	106000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-54893000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-49368000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	167904000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	265240000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-54893000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-49368000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	113011000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	215872000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	205863000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-23644000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-18000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	2282000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	706000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	183777000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-24805000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	281000	usd
CY2024Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	221000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	159026000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	306800000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-21147000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1824000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	287477000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-40732000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	2378000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	6000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	249129000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q3	lvwr	Proceeds From Reverse Capitalization Transaction ProceedsFromReverseCapitalizationTransaction	293700000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6449000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7026000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11427000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14788000	usd
CY2024Q2	lvwr	Variable Consideration Related To Previously Recognized Sales VariableConsiderationRelatedToPreviouslyRecognizedSales	5000	usd
	lvwr	Variable Consideration Related To Previously Recognized Sales VariableConsiderationRelatedToPreviouslyRecognizedSales	425000	usd
	lvwr	Variable Consideration Related To Previously Recognized Sales VariableConsiderationRelatedToPreviouslyRecognizedSales	250000	usd
CY2023Q2	lvwr	Variable Consideration Related To Previously Recognized Sales VariableConsiderationRelatedToPreviouslyRecognizedSales	250000	usd
CY2024Q2	lvwr	Revenue From Contract With Customer Refund Asset RevenueFromContractWithCustomerRefundAsset	153000	usd
CY2023Q4	lvwr	Revenue From Contract With Customer Refund Asset RevenueFromContractWithCustomerRefundAsset	299000	usd
CY2024Q2	lvwr	Revenue From Contract With Customer Refund Liability RevenueFromContractWithCustomerRefundLiability	181000	usd
CY2023Q4	lvwr	Revenue From Contract With Customer Refund Liability RevenueFromContractWithCustomerRefundLiability	327000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	183000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	214000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	341000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	245000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	183000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	341000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	15000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	85000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	85000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	163000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-40732000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-48449000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-61879000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	203184000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	202409000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	203136000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	202407000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	203184000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	202409000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	203136000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	202407000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2024Q2	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	0	usd
CY2023Q4	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	486000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	31443000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	28205000	usd
CY2024Q2	lvwr	Inventory Parts And Accessories And Apparel Net Of Reserves InventoryPartsAndAccessoriesAndApparelNetOfReserves	2619000	usd
CY2023Q4	lvwr	Inventory Parts And Accessories And Apparel Net Of Reserves InventoryPartsAndAccessoriesAndApparelNetOfReserves	3431000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	34062000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	32122000	usd
CY2024Q2	lvwr	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	3424000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	4249000	usd
CY2024Q2	lvwr	Accrued Engineering Current AccruedEngineeringCurrent	3356000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	1990000	usd
CY2023Q4	lvwr	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	4933000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	7077000	usd
CY2023Q4	lvwr	Accrued Engineering Current AccruedEngineeringCurrent	5215000	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	30499990	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2024Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1792000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6550000	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	11438000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	10370000	usd
CY2024Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	5769000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12319000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	882000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1011000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	566000	usd
CY2024Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	159000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	36000	usd
CY2024Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	216000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	74000	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	481000	usd
CY2024Q2	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-204000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	0	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-190000	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-3000	usd
CY2024Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	621000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	562000	usd
CY2024Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	621000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	562000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-28165000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-31984000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-58587000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-56891000	usd
CY2024Q2	us-gaap	Severance Costs1 SeveranceCosts1	2352000	usd
CY2024Q2	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	386000	usd
	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	462000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	usd
	us-gaap	Restructuring Charges RestructuringCharges	2544000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	554000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	1990000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001898795-24-000263-index-headers.html	Edgar Link	pending
0001898795-24-000263-index.html	Edgar Link	pending
0001898795-24-000263.txt	Edgar Link	pending
0001898795-24-000263-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lvwr-20240630.htm	Edgar Link	pending
lvwr-20240630.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lvwr-20240630_g1.jpg	Edgar Link	pending
lvwrexhibit3116-30x2024.htm	Edgar Link	pending
lvwrexhibit3126-30x2024.htm	Edgar Link	pending
lvwrexhibit3216-30x2024.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
lvwr-20240630_def.xml	Edgar Link	unprocessable
lvwr-20240630_lab.xml	Edgar Link	unprocessable
lvwr-20240630_pre.xml	Edgar Link	unprocessable
lvwr-20240630_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lvwr-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LVWR
LiveWire Group, Inc. Stock $lvwr

2024 Q3 Form 10-Q Financial Statement

#000189879524000263 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LVWR LiveWire Group, Inc. Stock $lvwr

2024 Q3 Form 10-Q Financial Statement

#000189879524000263 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LVWR
LiveWire Group, Inc. Stock $lvwr